13F

Stock

Syndax Pharmaceuticals Inc

SNDX · held by 12 managers

Reported value

$85.8M

Holders

12

+3 new · −0 exited

Holders’ est. mark

$2.1M

Price effect on 1 books still in the name

Largest holder

$56.9M

BANK OF AMERICA CORP /DE/

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BANK OF AMERICA CORP /DE/3.7M$56.9MHeld
MORGAN STANLEY1.2M$18.5MHeld
BARCLAYS PLC348.1K$5.35M$2.1MAdded$1.77M
Hudson Bay Capital Management LP250K$3.85MHeld
TUDOR INVESTMENT CORP ET AL50.2K$772.1KHeld
Sanctuary Advisors, LLC13.8K$169.3KNew
FARALLON CAPITAL MANAGEMENT LLC10K$153.8KNew
Cape Investment Advisory, Inc.6.44K$99.1KHeld
Essential Partners LLC923$14.2KNew
Allworth Financial LP745$11.5KHeld
IFP Advisors, Inc51$785Held
KBC Group NV5.18K$80Held

Positions as of Q3 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.